Guardant Health, Inc. (GH) Investor Relations Documents

Guardant Health, Inc. (GH) investor relations documents from the company's IR site: 15 presentations, 23 press releases; latest deck 2026-07-30. Read in-app with summaries. First-party data.

Presentation: Guardant Health Q2 2026 earnings presentation reports 44% year-over-year revenue growth to $335 million, driven by strong oncology and screening product adoption.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-07-30Earnings deckPresentation
2026-07-30Press releaseGuardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026
2026-07-29Press releaseGuardant Health to Participate in Upcoming Investor Conferences
2026-07-28Press releaseActor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who
2026-07-21Press releaseGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-01Press releaseUnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening
2026-06-02PresentationPresentation Open Event Link, PDF file, June 2, 2026, (opens in new window)
2026-05-07Press releaseGuardant Health Reports First Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
2026-05-07Earnings deckPresentation of Q1 2026, PDF file, (opens in new window)
2026-05-07Press releaseGuardant Health to Report First Quarter 2026 Financial Results on May 7, 2026
2026-04-21Press releaseGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-03-30Press releaseGuardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2
2026-03-18Press releaseGuardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of
2026-03-16Press releaseGuardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership
2026-03-13Press releaseNew Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should
2026-03-10Press releaseGuardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering
2026-03-04Press releaseGuardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities
2026-03-03Press releaseActor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Scree
2026-02-23Press releaseGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-02-19Press releasePress Release
2026-02-19Earnings deckGuardant Health Q4 and Full Year 2025 Earnings Call
2026-02-19Press releaseGuardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
2026-02-03Press releaseGuardant Health to Participate in Upcoming Investor Conferences
2026-02-02Press releaseLargest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test M
2026-01-22Press releaseGuardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combinati
2026-01-19Press releaseGuardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and C
2026-01-12PresentationPresentation Open Event Link, PDF file, January 12, 2026, (opens in new window)
2026-01-11Press releaseGuardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results
2025-12-23ESG reportTCFD Report 2025
2025-10-28PresentationPresentation
2025-07-29Earnings deckPresentation of Q2 2025 Press Release, (opens in new window)
2025-05-30ESG report2025 Corporate Responsibility Report of 2025, PDF file, (opens in new window)
2025-04-29PresentationSupplemental
2025-04-29Earnings deckGuardant Health Q1 2025 Earnings Call
2025-02-20Earnings deckGuardant Health Q4 2024 Earnings Call
2025-01-13Presentation43rd Annual J.P. Morgan Healthcare Conference
2024-11-06Earnings deckGuardant Health Q3 2024 Earnings Call
2024-08-07Earnings deckGuardant Health Q2 2024 Earnings Call
2024-06-04PresentationWilliam Blair 44th Annual Growth Stock Conference
2024-05-09Earnings deckGuardant Health Q1 2024 Earnings Call

GH overview · GH earnings · GH financials · GH KPIs · GH documents · GH ownership · GH peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.